Base to Base Biotech
The Base to Base Biotech podcast is a weekly look at what's happening in the world of biotech, with interviews with biotech leaders around the world.
Whether it's a new drug, cutting-edge technology, product launches, new technology, major finding announcement or clinical trial results, Base to Base Biotech keeps you informed.
The podcast is hosted by former biotech editor and broadcaster, the award-winning media veteran Jim Cornall.
Base to Base is an Ayr Coastal Media Ltd production.
- Update frequency
- every 6 days
- Average duration
- 49 minutes
- Episodes
- 25
- Years Active
- 2025
Base to Base biotech podcast 5: Vitalant’s vital role in blood products, and Brainomix gives hope to stroke victims
This week on the podcast, we have a conversation with Vitalant’s Kevin Land, executive medical director, Biotherapies, and VP of Clinical Services, and Becky Cap, SVP, Biotherapies; and chat with Bra…
Base to Base biotech podcast 4: A new class of therapeutics, and biotech hiring in 2025
This week on the podcast, we have conversations about hiring in the lifesciences industry in 2025, and about a potential new class of synthetic therapeutics.
Interview times:
02:49 ThirdLaw Molecular
…
Base to Base biotech podcast 3: Nanoparticles and Duchenne muscular dystrophy
Interview timestamps:
02:20 Satellos
26:00 EVŌQ Nano
Antibiotic-resistant infections are a top 10 global health threat demanding urgent innovation.
A US-based nanotech company, EVŌQ Nano, has developed…
Base to Base biotech podcast 2: Opioid alternatives and epiproteomics
Our guest, Dr. Hernan Bazan, is the CEO and co-founder of South Rampart Pharma. He is also a board-certified vascular surgeon.
Bazan is also the recipient of the 2024 NIH HEAL (Helping to End Addictio…
Base to Base biotech podcast 1: Osteoboost and Pheast Therapeutics
Osteoboost Health Inc. just announced its sixth U.S. patent for its wearable device that uses vibration therapy to strengthen bones and help women live stronger, longer lives.
The company is tackling …